Ad
ABUS Short Information Arbutus Biopharma Corporation
home / stock / abus / abus short
Short Information | Arbutus Biopharma Corporation (NASDAQ:ABUS)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 3,363,673 |
| Total Actual Volume | 17,492,268 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 168,184 |
| Average Short Percentage | 20.54% |
Is there a ABUS Short Squeeze or Breakout about to happen?
See the ABUS Short Analysis for free Sign up or Login
Powered by Squeeze Report
ABUS Twenty Trading Day's Volume to Short Volume Chart
ABUS Twenty Trading Day Price Chart
ABUS Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-22-2025 | $3.23 | $3.22 | $3.255 | $3.175 | 377,192 | 51,741 | 13.72% |
| 01-21-2025 | $3.19 | $3.21 | $3.25 | $3.16 | 481,149 | 75,472 | 15.69% |
| 01-17-2025 | $3.23 | $3.2 | $3.24 | $3.17 | 610,726 | 133,726 | 21.9% |
| 01-16-2025 | $3.3 | $3.22 | $3.3 | $3.16 | 721,299 | 150,674 | 20.89% |
| 01-15-2025 | $3.27 | $3.28 | $3.37 | $3.215 | 716,243 | 172,519 | 24.09% |
| 01-14-2025 | $3.38 | $3.18 | $3.38 | $3.18 | 751,142 | 201,616 | 26.84% |
| 01-13-2025 | $3.25 | $3.35 | $3.355 | $3.13 | 1,059,672 | 211,527 | 19.96% |
| 01-10-2025 | $3.33 | $3.29 | $3.33 | $3.235 | 836,736 | 158,775 | 18.98% |
| 01-08-2025 | $3.37 | $3.35 | $3.38 | $3.215 | 920,372 | 232,445 | 25.26% |
| 01-07-2025 | $3.27 | $3.41 | $3.54 | $3.25 | 1,595,621 | 400,076 | 25.07% |
| 01-06-2025 | $3.42 | $3.27 | $3.42 | $3.27 | 629,056 | 124,438 | 19.78% |
| 01-03-2025 | $3.29 | $3.42 | $3.445 | $3.285 | 629,575 | 180,237 | 28.63% |
| 01-02-2025 | $3.3 | $3.29 | $3.375 | $3.275 | 551,953 | 140,812 | 25.51% |
| 12-31-2024 | $3.24 | $3.27 | $3.285 | $3.21 | 727,427 | 178,085 | 24.48% |
| 12-30-2024 | $3.2 | $3.2 | $3.25 | $3.13 | 1,178,115 | 295,756 | 25.1% |
| 12-27-2024 | $3.16 | $3.21 | $3.22 | $3.115 | 831,166 | 160,474 | 19.31% |
| 12-26-2024 | $3.15 | $3.19 | $3.21 | $3.135 | 788,075 | 153,081 | 19.42% |
| 12-24-2024 | $3.21 | $3.18 | $3.21 | $3.11 | 370,783 | 53,119 | 14.33% |
| 12-23-2024 | $3.19 | $3.19 | $3.245 | $3.1501 | 722,268 | 116,080 | 16.07% |
| 12-20-2024 | $3.18 | $3.21 | $3.26 | $3.16 | 2,993,698 | 173,020 | 5.78% |
News, Short Squeeze, Breakout and More Instantly...
Arbutus Biopharma Corporation Company Name:
ABUS Stock Symbol:
NASDAQ Market:
Arbutus Biopharma Corporation Website:
Ad
-
Initiating Phase 2b clinical trial in first half of 2025 after achieving a meaningful functional cure rate in cHBV patients treated with imdusiran and interferon WARMINSTER, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the &...
-
Believes Now Is the Logical Time for Arbutus to Pursue a License and Collaboration Agreement With a Strategic Partner and Explore All Options for HBV Portfolio Urges Arbutus to Commit to No Dilutive Equity Issuances or ATM Use for Another Year Whitefort Formally Requests Meeting W...
-
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic he...